Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2026-03-02 @ 8:18 AM
Study NCT ID:
NCT03214250
Status:
COMPLETED
Last Update Posted:
2022-12-23
First Post:
2017-06-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Sponsor:
Parker Institute for Cancer Immunotherapy
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
PICI0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None